school of pharmacy research logo [View Image]

Institute for Structural Biology, Drug Discovery and Development

Dr. Yan Zhang Receives Supplement

August 25, 2020

Congratulations to Dr. Yan Zhang who has been awarded a supplement titled ' Novel fentanyl derivatives as counteracting agents against fentanyl'. Thisfurthers his current UG3 grant ' Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder' from NIDA. UG3 mechanism is an early phase exploratory cooperative agreement to assess clinical promise of novel agents.

View graphic versionView graphic versionView graphic version